## **Core Concept**
Pneumocystis carinii, now more commonly referred to as Pneumocystis jirovecii, is a fungus that primarily causes infection in individuals with weakened immune systems. The core concept here revolves around the opportunistic nature of this pathogen, particularly its affinity for causing disease in specific populations. P. jirovecii primarily affects the lungs, leading to Pneumocystis pneumonia (PCP).

## **Why the Correct Answer is Right**
The correct answer, , indicates that P. carinii (or P. jirovecii) primarily causes infection of the lungs. This is accurate because P. jirovecii is known to colonize and infect the alveoli of the lungs, leading to an inflammatory response and the clinical manifestations of PCP, which include cough, fever, and shortness of breath. The lung infection can be severe and life-threatening, especially in immunocompromised patients such as those with HIV/AIDS.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although P. jirovecii can disseminate to other parts of the body in severe cases, its primary site of infection is not the liver.
- **Option B:** This option is incorrect because the gastrointestinal tract is not the primary site of infection for P. jirovecii; the pathogen is primarily known for causing pulmonary infections.
- **Option C:** This option might seem plausible due to the possibility of extrapulmonary dissemination, but it is incorrect because the brain is not the primary site of infection.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that Pneumocystis jirovecii pneumonia (PCP) is an AIDS-defining illness. Prophylaxis against PCP is recommended for individuals with HIV/AIDS and a CD4 count below 200 cells/μL. TMP-SMX (trimethoprim-sulfamethoxazole) is the first-line treatment and prophylaxis for PCP.

## **Correct Answer:** . lungs